U.S. Treasury notes rose on Monday, amid U.S. personal spending and inflation data.
Financial stocks gained in Monday trading, leading the market higher as investors weighed the possibility of an impending interest rate hike.
Amid Mylan launching an EpiPen generic alternative, the “Fast Money Halftime Report” traders and CNBC’s Jim Cramer share their take on Mylan and the biotech sector.
The “Fast Money Halftime Report” traders, Sarat Sethi, Douglas C. Lane & Associates, and CNBC’s Jim Cramer share their take on the markets, and what they are keeping their eyes on in terms of a possible rate hike.
European stocks traded lower on Monday as the U.S. dollar strengthened after hawkish comments from U.S. Federal Reserve Chair Janet Yellen in a closely watched speech Friday.
U.S. stock-index futures pointed to a slightly higher open on Wall Street on Monday, ahead of personal spending and inflation data.
Japanese shares climbed on Monday, boosted by a weaker yen, but other Asian markets struggled after Fed officials on Friday suggested rates could rise soon.
Todd Gordon of TradingAnalysis.com is reading the Fed's interest rate tea leaves, and trying to score a big profit on an ETF.
CNBC's Melissa Lee and the Options Action traders look back at some open trades, with the focus on the TLT following Fed Chair Janet Yellen's remarks at Jackson Hole.
"Fast Money" trader Steve Grasso goes to the charts to look at key levels for the S&P 500.